Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

Federal Almazov North-West Medical Research Centre

Nom variantlari: Almazov National Medical Research Centre · Polenov Research Institute of Neurosurgery · федеральное государственное бюджетное учреждение Северо-Западный федеральный медицинский исследовательский центр имени В.А. Алмазова Министерства здравоохранения Российской Федерации

Davlat:
RU
ROR:
https://ror.org/03qepc107
3
h-indeks
42
Iqtiboslar
30
Asarlar
53
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
03581003581020162018201920202021202220232024202520262016: Nashrlar 1, Iqtiboslar 02018: Nashrlar 2, Iqtiboslar 02019: Nashrlar 3, Iqtiboslar 02020: Nashrlar 5, Iqtiboslar 02021: Nashrlar 3, Iqtiboslar 32022: Nashrlar 1, Iqtiboslar 62023: Nashrlar 7, Iqtiboslar 52024: Nashrlar 4, Iqtiboslar 82025: Nashrlar 2, Iqtiboslar 102026: Nashrlar 2, Iqtiboslar 10

Iqtibos tarixi

03581020162018201920202021202220232024202520262016: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 02020: Iqtiboslar 02021: Iqtiboslar 32022: Iqtiboslar 62023: Iqtiboslar 52024: Iqtiboslar 82025: Iqtiboslar 102026: Iqtiboslar 10

Nashr tarixi

03581020162018201920202021202220232024202520262016: Nashrlar 12018: Nashrlar 22019: Nashrlar 32020: Nashrlar 52021: Nashrlar 32022: Nashrlar 12023: Nashrlar 72024: Nashrlar 42025: Nashrlar 22026: Nashrlar 2

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520162018201920202021202220232024202520262016: h-indeks 02018: h-indeks 02019: h-indeks 02020: h-indeks 02021: h-indeks 12022: h-indeks 22023: h-indeks 22024: h-indeks 22025: h-indeks 22026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up20213 iqtibos
  2. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)20211 iqtibos
  3. The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries20231 iqtibos
  4. Clinical features of post-COVID period. Results of an International Register "Dynamics Analysis of Comorbidities in SARS-CoV-2 Survivors (ACTIV SARS-CoV-2)" (12-month follow-up)20220 iqtibos
  5. Current approaches in the treatment and rehabilitation of patients with neurological diseases after COVID-19. Resolution of the International Experts Forum20230 iqtibos
  6. The attitude of medical workers to telemedicine technologies.20230 iqtibos
  7. POSTER: CML-449 JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment20230 iqtibos
  8. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial20230 iqtibos
  9. Lymphocyte-monocyte index as a new marker for the prognosis of early recurrence of the disease in patients with glioblastoma20240 iqtibos
  10. Bladder exstrophy in children: evolution of diagnosis and modern trends in surgical treatment20240 iqtibos